ECM
MGNX icon

Endurant Capital Management’s MacroGenics MGNX Stock Holding History

Endurant Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-97,374
Closed -$2.45M – 67
2020
Q3 		$2.45M Buy
+97,374
New +$2.66M 0.73% 38
2020
Q2 		– Sell
-87,703
Closed -$510K – 68
2020
Q1 		$510K Sell
87,703
-35,197
-29% -$320K 0.23% 45
2019
Q4 		$1.34M Buy
+122,900
New +$1.22M 0.42% 40
2018
Q4 		– Sell
-39,456
Closed -$846K – 66
2018
Q3 		$846K Buy
+39,456
New +$841K 0.38% 51

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Endurant Capital Management's MGNX Position: Q4 2020 in Review

Endurant Capital Management sold out of MacroGenics (MGNX) in Q4 2020, closing a stake of 97,374 shares — an estimated $2.45M sold.

Endurant Capital Management first reported a position in MGNX in Q3 2018 and held it in 4 quarters. The position peaked at $2.45M in Q3 2020. 147 funds tracked by Wall St. Rank hold MGNX as of Q4 2020.

  • Endurant Capital Management reported no remaining MacroGenics position as of Q4 2020 after selling out during the quarter.
  • Endurant Capital Management sold 97,374 MacroGenics shares in Q4 2020, an estimated $2.45M.
  • Endurant Capital Management first reported a position in MacroGenics in Q3 2018 and held it in 4 quarters.
  • Endurant Capital Management's MacroGenics position peaked at $2.45M in Q3 2020.
  • 147 funds tracked by Wall St. Rank held MacroGenics as of Q4 2020.

Based on Endurant Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.